FDA, Diet Drug Maker Win Summary Judgment In Case Against Compounding Pharmacies

( May 14, 2025, 2:39 PM EDT) -- FORT WORTH, Texas — A Texas federal judge on May 13 made public his ruling that granted summary judgment to the U.S. Food and Drug Administration and to Eli Lilly and Co. in a dispute filed by companies representing the interests of drug compounders over whether the agency properly determined that the shortage of tirzepatide, a drug for diabetes and weight loss, had ended when it removed the drug from the agency’s drug shortage list....

Attached Documents

Related Sections